The Influence Of Maternal Infections On Congenital Heart Defect
Article Sidebar
Main Article Content
Abstract
ABSTRACT
Congenital heart defects (CHDs) contribute significantly to heightened infant mortality rates. This review explores the intricate link between maternal infections and CHDs, emphasizing diverse factors influencing fetal development, such as bacterial, fungal, protozoan and viral agents. These infections pose reproductive health risks, potentially leading to complications like prematurity, stillbirth and heart defect to the fetus. The TORCH acronym (Toxoplasma, Other infections, Rubella, Cytomegalovirus, Herpes simplex) identifies infectious teratogens related to congenital issues, emphasizing vertical transmission through the placenta or ascending from the vagina. Rubella and Cytomegalovirus play a significant role in heart defects, particularly when maternal infections amplify CHD risk during pregnancy. Specific scrutiny is placed on Rubella and Cytomegalovirus for their impact on pregnancy outcomes and potential links to congenital heart defects, with preventive strategies discussed, including vaccination and antiviral therapy. The timing and severity of these infections are pivotal in determining their impact on fetal heart development. Environmental exposures and maternal nutrition are critical factors influencing fetal development. Maternal undernutrition in low- and middle-income countries associates with adverse pregnancy outcomes, including congenital heart defects. Emphasizing the importance of maintaining a nutritious maternal diet, rich in essential nutrients, is crucial for improved fetal health and successful pregnancy outcomes. This review offers insights into preventive measures and underscores the need for continued research to enhance prenatal care strategies.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Megli, C. J., & Coyne, C. B. (2022). Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nature Reviews Microbiology, 20(2), 67-82.
Alberman, E., & Stanley, F. (1984). Guidelines to the epidemiological approach. The epidemiology of the cerebral palsies, 87.
Goldenberg, R. L., Culhane, J. F., & Johnson, D. C. (2005). Maternal infection and adverse fetal and neonatal outcomes. Clinics in perinatology, 32(3), 523-559.
Calado, A. M., & dos Anjos Pires, M. (2018). An overview of teratology. Teratogenicity Testing: Methods and Protocols, 3-32.
Bălălău, O. D., Olaru, O. G., Dumitru, A. V., Păunică, I., & Stănescu, A. D. (2020). Maternal infections with an increased risk of transmission to the foetus; a literature review. J Clin Invest Surg, 5(2), 66-72.
Tanimura, K., & Yamada, H. (2019). Maternal and neonatal screening methods for congenital cytomegalovirus infection. Journal of Obstetrics and Gynaecology Research, 45(3), 514-521.
McClure, E. M., & Goldenberg, R. L. (2009, August). Infection and stillbirth. In Seminars in Fetal and Neonatal Medicine (Vol. 14, No. 4, pp. 182-189). WB Saunders.
Moore, K. A., Simpson, J. A., Scoullar, M. J., McGready, R., & Fowkes, F. J. (2017). Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. The Lancet Global Health, 5(11), e1101-e1112.
DeSilva, M., Munoz, F. M., Mcmillan, M., Kawai, A. T., Marshall, H., Macartney, K. K., ... & Brighton Collaboration Congenital Anomalies Working Group. (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015.
Boyle, B., Addor, M. C., Arriola, L., Barisic, I., Bianchi, F., Csáky-Szunyogh, M., ... & Dolk, H. (2018). Estimating global burden of disease due to congenital anomaly: an analysis of European data. Archives of Disease in Childhood-Fetal and Neonatal Edition, 103(1), F22-F28.
Christianson, A. L., Howson, C. P., & Modell, B. (2006). Global report on birth defects: the hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation.
Spinillo, A., Iacobone, A. D., Calvino, I. G., Alberi, I., & Gardella, B. (2014). The role of the placenta in feto-neonatal infections. Early human development, 90, S7-S9.
Woodd, S. L., Montoya, A., Barreix, M., Pi, L., Calvert, C., Rehman, A. M., ... & Campbell, O. M. (2019). Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS medicine, 16(12), e1002984.
Turbadkar, D., Mathur, M., & Rele, M. (2003). Seroprevalence of torch infection in bad obstetric history. Indian journal of medical microbiology, 21(2), 108-110.
World Health Organization. (2015). Strategic plan for measles elimination and rubella and congenital rubella syndrome control in the South-East Asia Region, 2014-2020.
Lawn, J. E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., ... & Draper, E. S. (2016). Stillbirths: rates, risk factors, and acceleration towards 2030. The Lancet, 387(10018), 587-603.
McClure, E. M., Silver, R. M., Kim, J., Ahmed, I., Kallapur, M., Ghanchi, N., ... & Goldenberg, R. L. (2022). Maternal infection and stillbirth: a review. The Journal of Maternal-Fetal & Neonatal Medicine, 35(23), 4442-4450.
Seale, A. C., Blencowe, H., Manu, A. A., Nair, H., Bahl, R., Qazi, S. A., ... & Lawn, J. E. (2014). Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. The Lancet infectious diseases, 14(8), 731-741.
Akoijam, B. S., Singh, S., & Kapoor, S. K. (2002). Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. Journal of the Indian Medical Association, 100(10), 591-2.
Singh, S., & Nautiyal, B. L. (1991). Seroprevalence of toxoplasmosis in Kumaon region of India. The Indian Journal of Medical Research, 93, 247-249.
Neu, N., Duchon, J., & Zachariah, P. (2015). TORCH infections. Clinics in perinatology, 42(1), 77-103.
Stegmann, B. J., & Carey, J. C. (2002). TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. Current women's health reports, 2(4), 253-258.
Robbins, J. R., & Bakardjiev, A. I. (2012). Pathogens and the placental fortress. Current opinion in microbiology, 15(1), 36-43.
Richardson, A. N., Pollak, E. A., Williams, D., & Smith, M. A. (2010). Intrauterine infection.
Edwards, T. M., & Myers, J. P. (2007). Environmental exposures and gene regulation in disease etiology. Environmental health perspectives, 115(9), 1264-1270.
Gonzalez-Casanova, I., Stein, A. D., Barraza-Villarreal, A., Feregrino, R. G., DiGirolamo, A., Hernandez-Cadena, L., ... & Ramakrishnan, U. (2018). Prenatal exposure to environmental pollutants and child development trajectories through 7 years. International journal of hygiene and environmental health, 221(4), 616-622.
O'Toole, T. E., Conklin, D. J., & Bhatnagar, A. (2008). Environmental risk factors for heart disease. Reviews on environmental health, 23(3), 167-202.
Kalisch-Smith, J. I., Ved, N., & Sparrow, D. B. (2020). Environmental risk factors for congenital heart disease. Cold Spring Harbor perspectives in biology, 12(3), a037234.
Gregg, N. M. (1941). Congenital cataract following German measles in the mother. Problems of Birth Defects: From Hippocrates to Thalidomide and After, 170-180.
Volkow, N. D., Compton, W. M., & Wargo, E. M. (2017). The risks of marijuana use during pregnancy. Jama, 317(2), 129-130.
Metz, T. D., & Stickrath, E. H. (2015). Marijuana use in pregnancy and lactation: a review of the evidence. American journal of obstetrics and gynecology, 213(6), 761-778.
Behrooz, L., Balekian, D. S., Faridi, M. K., Espinola, J. A., Townley, L. P., & Camargo Jr, C. A. (2018). Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy. Respiratory medicine, 140, 21-26.
Ion, R., & Bernal, A. L. (2015). Smoking and preterm birth. Reproductive Sciences, 22(8), 918-926.
Organization WH. Global Strategy for Prevention and Control of Sexually Transmitted Infections: 2006–2105. Geneva, Switzerland: World Health Organization, 2006.
Silveira, M. F., Ghanem, K. G., Erbelding, E. J., Burke, A. E., Johnson, H. L., Singh, R. H., & Zenilman, J. M. (2009). Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study. International journal of STD & AIDS, 20(7), 465-469.
Woods, C. R. (2005, October). Gonococcal infections in neonates and young children. In Seminars in pediatric infectious diseases (Vol. 16, No. 4, pp. 258-270). WB Saunders. infectious diseases. 2005; 16258–70. Epub 2005/10/08. https://doi.org/10.1053/j.spid.2005.06.006 PMID: 16210106
Hammerschlag, M. R. (2011). Chlamydial and gonococcal infections in infants and children. Clinical infectious diseases, 53(suppl_3), S99-S102.
Walker, D. G., & Walker, G. J. (2002). Forgotten but not gone: the continuing scourge of congenital syphilis. The Lancet infectious diseases, 2(7), 432-436.
Walker, G. J., & Walker, D. G. (2007, June). Congenital syphilis: a continuing but neglected problem. In seminars in fetal and Neonatal medicine (Vol. 12, No. 3, pp. 198-206). WB Saunders.
Woods, C. R. (2009). Congenital syphilis–persisting pestilence. The Pediatric infectious disease journal, 28(6), 536-537.
Woods, C. R. (2005, October). Syphilis in children: congenital and acquired. In Seminars in pediatric infectious diseases (Vol. 16, No. 4, pp. 245-257). WB Saunders.
Workowski, K. A. (2015). Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases, 61(suppl_8), S759-S762.
Langel, S. N., Blasi, M., & Permar, S. R. (2022). Maternal immune protection against infectious diseases. Cell Host & Microbe, 30(5), 660-674.
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., McNeil, M. M., Naleway, A. L., Klein, N. P., ... & Omer, S. B. (2015). Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. Jama, 314(15), 1581-1587.
Bakker, M. K., Jentink, J., Vroom, F., Van Den Berg, P. B., De Walle, H. E., & De Jong‐Van Den Berg, L. T. W. (2006). Maternal medicine: Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy‐related drugs in the Netherlands. BJOG: An International Journal of Obstetrics & Gynaecology, 113(5), 559-568.
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. (2010). Valproic acid monotherapy in pregnancy and major congenital malformations. New England Journal of Medicine, 362(23), 2185-2193.
Howard, T. B., Tassinari, M. S., Feibus, K. B., & Mathis, L. L. (2011, August). Monitoring for teratogenic signals: pregnancy registries and surveillance methods. In American Journal of Medical Genetics Part C: Seminars in Medical Genetics (Vol. 157, No. 3, pp. 209-214). Hoboken: Wiley Subscription Services, Inc., A Wiley Company.
Artama, M., Gissler, M., Malm, H., Ritvanen, A., & Drugs and Pregnancy Study Group. (2011). Nationwide register‐based surveillance system on drugs and pregnancy in Finland 1996–2006. Pharmacoepidemiology and drug safety, 20(7), 729-738.
Fisher, S. C., Van Zutphen, A. R., Werler, M. M., Lin, A. E., Romitti, P. A., Druschel, C. M., & Browne, M. L. (2017). Maternal antihypertensive medication use and congenital heart defects: updated results from the National Birth Defects Prevention Study. Hypertension, 69(5), 798-805.
Van Gelder, M. M. H. J., Van Bennekom, C. M., Louik, C., Werler, M. M., Roeleveld, N., & Mitchell, A. A. (2015). Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case–control study. BJOG: An International Journal of Obstetrics & Gynaecology, 122(7), 1002-1009.
Van Zutphen, A. R., Werler, M. M., Browne, M. M., Romitti, P. A., Bell, E. M., McNutt, L. A., ... & Mitchell, A. A. (2014). Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstetrics and gynecology, 123(2 Pt 1), 309.
Elango, R., & Ball, R. O. (2016). Protein and amino acid requirements during pregnancy. Advances in nutrition, 7(4), 839S-844S.
Saccone, G., & Berghella, V. (2015). Omega-3 supplementation to prevent recurrent preterm birth: a systematic review and metaanalysis of randomized controlled trials. American journal of obstetrics and gynecology, 213(2), 135-140.
Mousa, A., Naqash, A., & Lim, S. (2019). Macronutrient and micronutrient intake during pregnancy: an overview of recent evidence. Nutrients, 11(2), 443.
Lowensohn, R. I., Stadler, D. D., & Naze, C. (2016). Current concepts of maternal nutrition. Obstetrical & gynecological survey, 71(7), 413.
Black, R. E., Victora, C. G., Walker, S. P., Bhutta, Z. A., Christian, P., De Onis, M., ... & Uauy, R. (2013). Maternal and child undernutrition and overweight in low-income and middle-income countries. The lancet, 382(9890), 427-451.
Wu, G., Imhoff‐Kunsch, B., & Girard, A. W. (2012). Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatric and perinatal epidemiology, 26, 4-26.
Nnam, N. M. (2015). Improving maternal nutrition for better pregnancy outcomes. Proceedings of the Nutrition Society, 74(4), 454-459.
Villar, J., Merialdi, M., Gulmezoglu, A. M., Abalos, E., Carroli, G., Kulier, R., & de Onis, M. (2003). Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. The Journal of nutrition, 133(5), 1606S-1625S.
Fall, C. H., Yajnik, C. S., Rao, S., Davies, A. A., Brown, N., & Farrant, H. J. (2003). Micronutrients and fetal growth. The Journal of nutrition, 133(5), 1747S-1756S.
Bhutta, Z. A., Darmstadt, G. L., Hasan, B. S., & Haws, R. A. (2005). Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence. Pediatrics, 115(Supplement_2), 519-617.
Bastos Maia, S., Rolland Souza, A. S., Costa Caminha, M. D. F., Lins da Silva, S., Callou Cruz, R. D. S. B. L., Carvalho dos Santos, C., & Batista Filho, M. (2019). Vitamin A and pregnancy: a narrative review. Nutrients, 11(3), 681.
McCauley, M. E., van den Broek, N., Dou, L., & Othman, M. (2015). Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database of Systematic Reviews, (10).
Sobczyńska-Malefora, A., & Harrington, D. J. (2018). Laboratory assessment of folate (vitamin B9) status. Journal of clinical pathology, 71(11), 949-956.
Breymann, C. (2015, October). Iron deficiency anemia in pregnancy. In Seminars in hematology (Vol. 52, No. 4, pp. 339-347). WB Saunders.
Evenson, K. R., & Wen, F. (2011). Prevalence and correlates of objectively measured physical activity and sedentary behavior among US pregnant women. Preventive medicine, 53(1-2), 39-43.
Beto, J. A. (2015). The role of calcium in human aging. Clinical nutrition research, 4(1), 1-8.
Holick, M. F., & Chen, T. C. (2008). Vitamin D deficiency: a worldwide problem with health consequences. The American journal of clinical nutrition, 87(4), 1080S-1086S.
Holick, M. F. (2006). The role of vitamin D for bone health and fracture prevention. Current osteoporosis reports, 4(3), 96-102.
Hazell, T. J., DeGuire, J. R., & Weiler, H. A. (2012). Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescents. Nutrition reviews, 70(9), 520-533.
Trivedi, D. P., Doll, R., & Khaw, K. T. (2003). Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. Bmj, 326(7387), 469.
Bath, S. C. (2019). The effect of iodine deficiency during pregnancy on child development. Proceedings of the Nutrition Society, 78(2), 150-160.
Zimmermann, M. B., Gizak, M., Abbott, K., Andersson, M., & Lazarus, J. H. (2015). Iodine deficiency in pregnant women in Europe. The lancet Diabetes & endocrinology, 3(9), 672-674.
Kambe, T., Fukue, K., Ishida, R., & Miyazaki, S. (2015). Overview of inherited zinc deficiency in infants and children. Journal of nutritional science and vitaminology, 61(Supplement), S44-S46.
Terrin, G., Berni Canani, R., Di Chiara, M., Pietravalle, A., Aleandri, V., Conte, F., & De Curtis, M. (2015). Zinc in early life: a key element in the fetus and preterm neonate. Nutrients, 7(12), 10427-10446.
World Health Organization. (2005). The World Health Report 2005: Make every mother and child count. World Health Organization.
Chan, M. Y., & Smith, M. A. (2018). Infections in pregnancy. Comprehensive toxicology, 232.
Silasi, M., Cardenas, I., Kwon, J. Y., Racicot, K., Aldo, P., & Mor, G. (2015). Viral infections during pregnancy. American journal of reproductive immunology, 73(3), 199-213.
Racicot, K., & Mor, G. (2017). Risks associated with viral infections during pregnancy. The Journal of clinical investigation, 127(5), 1591-1599.
Thomas, J. R., Appios, A., Zhao, X., Dutkiewicz, R., Donde, M., Lee, C. Y., ... & McGovern, N. (2021). Phenotypic and functional characterization of first-trimester human placental macrophages, Hofbauer cells. Journal of Experimental Medicine, 218(1).
Mate, A., Reyes-Goya, C., Santana-Garrido, Á., Sobrevia, L., & Vázquez, C. M. (2021). Impact of maternal nutrition in viral infections during pregnancy. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1867(11), 166231.
O’Leary, S. T., Riley, L. E., Lindley, M. C., Allison, M. A., Crane, L. A., Hurley, L. P., ... & Kempe, A. (2018). Immunization practices of US obstetrician/gynecologists for pregnant patients. American journal of preventive medicine, 54(2), 205-213.
Thompson, K. M., Simons, E. A., Badizadegan, K., Reef, S. E., & Cooper, L. Z. (2016). Characterization of the risks of adverse outcomes following rubella infection in pregnancy. Risk Analysis, 36(7), 1315-1331.
Drutz, J. E. (2010). Rubella.
Webster, W. S. (1998). Teratogen update: congenital rubella. Teratology, 58(1), 13-23.
Kimberlin, D. W. (2018). Red Book: 2018-2021 report of the committee on infectious diseases (No. Ed. 31). American academy of pediatrics.
Davis, N. L., King, C. C., & Kourtis, A. P. (2017). Cytomegalovirus infection in pregnancy. Birth defects research, 109(5), 336-346.
Britt, W. (2015). Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Medical microbiology and immunology, 204, 263-271.
Khan, R., Ranganathan, M., & Mondal, T. (2015). Congenital cytomegalovirus (Cmv) infection and ascending aorta dilation. J Cardiol Curr Res, 4(1), 00130.
Sakaguchi, H., Yamamoto, T., Ono, S., Akashi, A., Tsuda, E., & Watanabe, K. (2012). An infant case of dilated cardiomyopathy associated with congenital cytomegalovirus infection. Pediatric cardiology, 33, 824-826.
Manzoor, N., Rehan, A., Akmal, M., Khalid, T. B., & Jamal, A. (2019). Congenital cytomegalovirus infection and tetralogy of fallot: an unusual association in a three-month-old baby. Cureus, 11(6).
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015). Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PloS one, 10(10), e0140765.
Looker, K. J., Magaret, A. S., Turner, K. M., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PloS one, 10(1), e114989.
Mustafa, M., Illzam, E., Muniandy, R., Sharifah, A., Nang, M., & Ramesh, B. (2016). Herpes simplex virus infections, Pathophysiology and Management. IOSR J dent med sci, 15(07), 85-91.
James, C., Harfouche, M., Welton, N. J., Turner, K. M., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J. (2020). Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 98(5), 315.
Knipe, D. M., Howley, P. M., Cohen, J. I., Griffin, D. E., Lamb, R. A., Martin, M. A., ... & Roizman, B. (2013). Fields virology, Lippincott Williams & Wilkins. Philadelphia, PA.[Google Scholar].
Hammad, W. A. B., & Konje, J. C. (2021). Herpes simplex virus infection in pregnancy–An update. European Journal of Obstetrics & Gynecology and Reproductive Biology, 259, 38-45.
Lee, R., & Nair, M. (2017). Diagnosis and treatment of herpes simplex 1 virus infection in pregnancy. Obstetric Medicine, 10(2), 58-60.
Wedi, C. O., Kirtley, S., Hopewell, S., Corrigan, R., Kennedy, S. H., & Hemelaar, J. (2016). Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. The lancet HIV, 3(1), e33-e48.
Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015). HIV infection. Nature reviews Disease primers, 1(1), 1-22.
Spector, S. A. (2001). Mother-to-infant transmission of HIV-1: the placenta fights back. The Journal of clinical investigation, 107(3), 267-269.
Ellington, S. R., King, C. C., & Kourtis, A. P. (2011). Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition. Future virology, 6(12), 1451-1469.
Cihlar, T., & Fordyce, M. (2016). Current status and prospects of HIV treatment. Current opinion in virology, 18, 50-56.
Maartens, G., Celum, C., & Lewin, S. R. (2014). HIV infection: epidemiology, pathogenesis, treatment, and prevention. The Lancet, 384(9939), 258-271.
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., ... & Yamanishi, K. (2015). Varicella zoster virus infection. Nature reviews Disease primers, 1(1), 1-18.
Gershon, A. A. (2011). Varicella-zoster vaccine.
Mysore, K. R., & Leung, D. H. (2018). Hepatitis b and c. Clinics in Liver Disease, 22(4), 703-722.
Keilman, L. J. (2019). Seasonal influenza (flu). Nursing Clinics, 54(2), 227-243.
Wang, R., Yan, W., Du, M., Tao, L., & Liu, J. (2021). The effect of influenza virus infection on pregnancy outcomes: A systematic review and meta-analysis of cohort studies. International Journal of Infectious Diseases, 105, 567-578.
Musso, D., & Gubler, D. J. (2016). Zika virus. Clinical microbiology reviews, 29(3), 487-524.
Landry, M. L. (2016). Parvovirus B19. Microbiology Spectrum, 4(3), 10-1128.
He, F., Deng, Y., & Li, W. (2020). Coronavirus disease 2019: What we know?. Journal of medical virology, 92(7), 719-725.
Alzamora, M. C., Paredes, T., Caceres, D., Webb, C. M., Valdez, L. M., & La Rosa, M. (2020). Severe COVID-19 during pregnancy and possible vertical transmission. American journal of perinatology, 37(08), 861-865.
da Cunha, R. V., & Trinta, K. S. (2017). Chikungunya virus: clinical aspects and treatment-A Review. Memórias do Instituto Oswaldo Cruz, 112, 523-531.
Paixão, E. S., Teixeira, M. G., Maria da Conceição, N. C., & Rodrigues, L. C. (2016). Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. The Lancet infectious diseases, 16(7), 857-865.
França, G. V., Schuler-Faccini, L., Oliveira, W. K., Henriques, C. M., Carmo, E. H., Pedi, V. D., ... & Victora, C. G. (2016). Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. The lancet, 388(10047), 891-897.
Evans-Gilbert, T. (2020). Vertically transmitted chikungunya, Zika and dengue virus infections: The pathogenesis from mother to fetus and the implications of co-infections and vaccine development. International Journal of Pediatrics and Adolescent Medicine, 7(3), 107-111.
Xiao, Y., & Cai, W. (2020). Autophagy and bacterial infection. Autophagy: Biology and Diseases: Clinical Science, 413-423.
Fisher, R. A., Gollan, B., & Helaine, S. (2017). Persistent bacterial infections and persister cells. Nature Reviews Microbiology, 15(8), 453-464.
Deusenbery, C., Wang, Y., & Shukla, A. (2021). Recent innovations in bacterial infection detection and treatment. ACS Infectious Diseases, 7(4), 695-720.
Raabe, V. N., & Shane, A. L. (2019). Group B streptococcus (Streptococcus agalactiae). Microbiology spectrum, 7(2), 10-1128.
Hall, J., Adams, N. H., Bartlett, L., Seale, A. C., Lamagni, T., Bianchi-Jassir, F., ... & Gravett, M. G. (2017). Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clinical infectious diseases, 65(suppl_2), S112-S124.
Slotved, H. C., Kong, F., Lambertsen, L., Sauer, S., & Gilbert, G. L. (2007). Serotype IX, a proposed new Streptococcus agalactiae serotype. Journal of clinical microbiology, 45(9), 2929-2936.
Edwards, M. S., Rench, M. A., & Baker, C. J. (2015). Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. The Pediatric Infectious Disease Journal, 34(5), 538-539.
Alhhazmi, A., Hurteau, D., & Tyrrell, G. J. (2016). Epidemiology of invasive group B streptococcal disease in Alberta, Canada, from 2003 to 2013. Journal of clinical microbiology, 54(7), 1774-1781.
Skoff, T. H., Farley, M. M., Petit, S., Craig, A. S., Schaffner, W., Gershman, K., ... & Schrag, S. J. (2009). Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clinical Infectious Diseases, 49(1), 85-92.
Chaiwarith, R., Jullaket, W., Bunchoo, M., Nuntachit, N., Sirisanthana, T., & Supparatpinyo, K. (2011). Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study. BMC infectious diseases, 11(1), 1-7.
Tazi, A., Morand, P. C., Réglier‐Poupet, H., Dmytruk, N., Billoët, A., Antona, D., ... & Poyart, C. (2011). Invasive group B streptococcal infections in adults, France (2007–2010). Clinical microbiology and infection, 17(10), 1587-1589.
Ulett, K. B., Benjamin Jr, W. H., Zhuo, F., Xiao, M., Kong, F., Gilbert, G. L., ... & Ulett, G. C. (2009). Diversity of group B streptococcus serotypes causing urinary tract infection in adults. Journal of clinical microbiology, 47(7), 2055-2060.
Kimberlin, D. W., Brady, M. T., Jackson, M. A., & Long, S. S. (2015). One cl.
Madjunkov, M., Chaudhry, S., & Ito, S. (2017). Listeriosis during pregnancy. Archives of gynecology and obstetrics, 296, 143-152.
Schlech WF 3rd, Lavigne PM, Bortolussi RA, Allen AC, Haldane EV, Wort AJ, Hightower AW, Johnson SE, King SH, Nicholls ES, Broome CV (1983) Epidemic listeriosis—evidence for transmission by food. N Engl J Med 308(4):203–206
Mateus T, Silva J, Maia RL, Teixeira P (2013) Listeriosis during pregnancy: a public health concern. ISRN Obstet Gynecol 26(851712):851712
Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De Valk H, Desenclos JC (2012) Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis 54(5):652–660.
Wadhwa Desai, R., & Smith, M. A. (2017). Pregnancy‐related listeriosis. Birth defects research, 109(5), 324-335.
Mylonakis, E., Paliou, M., Hohmann, E. L., Calderwood, S. B., & Wing, E. J. (2002). Listeriosis during pregnancy: a case series and review of 222 cases. Medicine, 81(4), 260-269.
Janakiraman, V. (2008). Listeriosis in pregnancy: diagnosis, treatment, and prevention. Reviews in Obstetrics and Gynecology, 1(4), 179.
Khsim, I. E. F., Mohanaraj‐Anton, A., Horte, I. B., Lamont, R. F., Khan, K. S., Jørgensen, J. S., & Amezcua‐Prieto, C. (2022). Listeriosis in pregnancy: An umbrella review of maternal exposure, treatment and neonatal complications. BJOG: An International Journal of Obstetrics & Gynaecology, 129(9), 1427-1433.
Wang, Z., Tao, X., Liu, S., Zhao, Y., & Yang, X. (2021). An update review on Listeria infection in pregnancy. Infection and drug resistance, 1967-1978.
World Health Organization, & Centers for Disease Control and Prevention. (2012). Investment case for eliminating mother-to-child transmission of syphilis: promoting better maternal and child health and stronger health systems.
Rac, M. W., Revell, P. A., & Eppes, C. S. (2017). Syphilis during pregnancy: a preventable threat to maternal-fetal health. American journal of obstetrics and gynecology, 216(4), 352-363.
De Santis, M., De Luca, C., Mappa, I., Spagnuolo, T., Licameli, A., Straface, G., & Scambia, G. (2012). Syphilis infection during pregnancy: fetal risks and clinical management. Infectious diseases in obstetrics and gynecology, 2012.
Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bulletin of the World Health Organization, 91, 217-226.
World Health Organization. Methods for surveillance and monitoring of congenital syphilis e elimination within existing systems [Internet]. Geneva: World Health Organization; 2011 [cited 2014 Out 05].
Uku, A., Albujasim, Z., Dwivedi, T., Ladipo, Z., & Konje, J. C. (2021). Syphilis in pregnancy: The impact of “the Great Imitator”. European Journal of Obstetrics & Gynecology and Reproductive Biology, 259, 207-210.
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017). The changing epidemiology of invasive fungal infections. Human fungal pathogen identification: methods and protocols, 17-65.
Alter, S. J., McDonald, M. B., Schloemer, J., Simon, R., & Trevino, J. (2018). Common child and adolescent cutaneous infestations and fungal infections. Current problems in pediatric and adolescent health care, 48(1), 3-25.
Soong, D., & Einarson, A. (2009). Vaginal yeast infections during pregnancy. Canadian family physician, 55(3), 255.
Aguin, T. J., & Sobel, J. D. (2015). Vulvovaginal candidiasis in pregnancy. Current infectious disease reports, 17, 1-6.
Hani, U., G Shivakumar, H., Vaghela, R., Osmani, A. M., & Shrivastava, A. (2015). Candidiasis: A fungal infection-current challenges and progress in prevention and treatment. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 15(1), 42-52.
Geiser, D. M. (2009). Sexual structures in Aspergillus: morphology, importance and genomics. Medical mycology, 47(sup1), S21-S26.
Jenks, J. D., & Hoenigl, M. (2018). Treatment of aspergillosis. Journal of Fungi, 4(3), 98.
Sehgal, I. S., Dhooria, S., Thurai Prasad, K., Muthu, V., Aggarwal, A. N., Chakrabarti, A., & Agarwal, R. (2021). Pregnancy complicated by allergic bronchopulmonary aspergillosis: A case‐control study. Mycoses, 64(1), 35-41.
Patel, A. R., Patel, A. R., Singh, S., Singh, S., & Khawaja, I. (2019). Treating allergic bronchopulmonary aspergillosis: a review. Cureus, 11(4).
Wood, C. L., & Johnson, P. T. (2015). A world without parasites: exploring the hidden ecology of infection. Frontiers in Ecology and the Environment, 13(8), 425-434.
Mahande, A. M., & Mahande, M. J. (2016). Prevalence of parasitic infections and associations with pregnancy complications and outcomes in northern Tanzania: a registry-based cross-sectional study. BMC infectious diseases, 16, 1-9.
Taylor, S. M., Van Eijk, A. M., Hand, C. C., Mwandagalirwa, K., Messina, J. P., Tshefu, A. K., ... & Ter Kuile, F. O. (2011). Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo. Journal of Infectious Diseases, 204(11), 1762-1771.
Ahenkorah, B., Nsiah, K., Baffoe, P., Ofosu, W., Gyasi, C., & Owiredu, E. W. (2020). Parasitic infections among pregnant women at first antenatal care visit in northern Ghana: a study of prevalence and associated factors. PloS one, 15(7), e0236514.
Ahmed, M., Sood, A., & Gupta, J. (2020). Toxoplasmosis in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 255, 44-50.
Rostami, A., Riahi, S. M., Gamble, H. R., Fakhri, Y., Shiadeh, M. N., Danesh, M., ... & Gasser, R. B. (2020). Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection, 26(6), 673-683.
Picone, O., Fuchs, F., Benoist, G., Binquet, C., Kieffer, F., Wallon, M., ... & Villena, I. (2020). Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. Journal of gynecology obstetrics and human reproduction, 49(7), 101814.
Dunn, D., Wallon, M., Peyron, F., Petersen, E., Peckham, C., & Gilbert, R. (2000). Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling. Obstetrical & Gynecological Survey, 55(1), 6.
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000). Toxoplasma gondii: from animals to humans. International journal for parasitology, 30(12-13), 1217-1258.
Khan, K., & Khan, W. (2018). Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitology International, 67(6), 715-721.
Villard, O., Cimon, B., L’ollivier, C., Fricker-Hidalgo, H., Godineau, N., Houze, S., ... & Candolfi, E. (2016). Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagnostic Microbiology and Infectious Disease, 84(1), 22-33.
Vidigal, P. V. T., Santos, D. V. V., Castro, F. C., Couto, J. C. D. F., Vitor, R. W. D. A., & Brasileiro Filho, G. (2002). Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Revista da Sociedade Brasileira de Medicina Tropical, 35, 1-6.
Talapko, J., Škrlec, I., Alebić, T., Jukić, M., & Včev, A. (2019). Malaria: the past and the present. Microorganisms, 7(6), 179.
WHO (2015). The World Malaria Report http://wwwwhoint/malaria/publications/world-malaria-report-2015/report/en/ ISBN 978 92 4 156515 8.
Bauserman, M., Conroy, A. L., North, K., Patterson, J., Bose, C., & Meshnick, S. (2019, August). An overview of malaria in pregnancy. In Seminars in perinatology (Vol. 43, No. 5, pp. 282-290). WB Saunders.
Rogerson, S. J. (2017). Management of malaria in pregnancy. The Indian journal of medical research, 146(3), 328.
Feeney, M. E. (2020). The immune response to malaria in utero. Immunological reviews, 293(1), 216-229.
Tuteja, R. (2007). Malaria− an overview. The FEBS journal, 274(18), 4670-4679.
Duffy, P. E., & Patrick Gorres, J. (2020). Malaria vaccines since 2000: progress, priorities, products. npj Vaccines, 5(1), 48.
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., & Park, I. (2021). PUBLICATIONS| December 2021.
Centers for Disease Control and Prevention. Trichomoniasis - CDC Fact Sheet, Division of STD Prevention, Editor 2012.
Meites, E., Gaydos, C. A., Hobbs, M. M., Kissinger, P., Nyirjesy, P., Schwebke, J. R., ... & Workowski, K. A. (2015). A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections. Clinical infectious diseases, 61(suppl_8), S837-S848.
Schumann, J. A., & Plasner, S. (2022). Trichomoniasis. In StatPearls [Internet]. StatPearls Publishing.
Crosby, R., DiClemente, R. J., Wingood, G. M., Harrington, K., Davies, S. L., Hook, E. W., & Oh, M. K. (2002). Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sexually Transmitted Infections, 78(5), 360-364.
Kissinger, P. (2015). Epidemiology and treatment of trichomoniasis. Current infectious disease reports, 17, 1-9.
de Brum Vieira, P., Tasca, T., & Evan Secor, W. (2017). Challenges and persistent questions in the treatment of Trichomoniasis. Current topics in medicinal chemistry, 17(11), 1249-1265.
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., ... & Turner, M. B. (2012). Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation, 125(1), e2-e220.
Sun, R., Liu, M., Lu, L., Zheng, Y., & Zhang, P. (2015). Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell biochemistry and biophysics, 72, 857-860.
Gorini, F., Chiappa, E., Gargani, L., & Picano, E. (2014). Potential effects of environmental chemical contamination in congenital heart disease. Pediatric cardiology, 35, 559-568.
Oster, M. E., Riehle‐Colarusso, T., & Correa, A. (2010). An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Research Part A: Clinical and Molecular Teratology, 88(1), 1-8.
Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., ... & Webb, C. L. (2007). Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation, 115(23), 2995-3014.
Campbell, M. (1961). Place of maternal rubella in the aetiology of congenital heart disease. British medical journal, 1(5227), 691.
Waldorf, K. M. A., & McAdams, R. M. (2013). Influence of infection during pregnancy on fetal development. Reproduction, 146(5), R151-R162.
Li, M., Liu, Z., Lin, Y., Chen, X., Li, S., You, F., ... & Zhu, J. (2014). Maternal influenza-like illness, medication use during pregnancy and risk of congenital heart defects in offspring. The Journal of Maternal-Fetal & Neonatal Medicine, 27(8), 807-811.
Thinkhamrop, J., Hofmeyr, G. J., Adetoro, O., Lumbiganon, P., & Ota, E. (2015). Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane database of systematic reviews, (1).
Autti-Ramo I, Fagerlund A, Ervalahti N, Loimu L, Korkman M, Hoyme HE (2006) Fetal alcohol spectrum disorders in Finland: clinical delineation of 77 older children and adolescents. Am J Med Genet A 140:137–143
Ou, Y., Mai, J., Zhuang, J., Liu, X., Wu, Y., Gao, X., ... & Lin, S. (2016). Risk factors of different congenital heart defects in Guangdong, China. Pediatric research, 79(4), 549-558.